The Board of Directors of
In order ensure that BONESUPPORT can fulfill its obligations under the incentive program LTI 2023 resolved by the 2023 annual general meeting, the 2023 annual general meeting authorized the Board of Directors to resolve on a directed issue of redeemable and convertible series C shares and repurchase of all issued series C shares through a directed acquisition offer to all holders of series C shares.
On
Prior to the delivery of performance shares to employees within the
The total number of shares in BONESUPPORT at the time of this press release amounts to 66,197,635, of which 65,055,575 ordinary shares and 1,142,060 series C shares. BONESUPPORT holds at the time of this press release no own ordinary shares and 1,142,060 own series C shares, intended for ongoing incentive programs. After the ongoing conversion of series C shares into ordinary shares and the ongoing issue of series C shares, the total number of shares will amount to 66,684,475, of which 65,719,320 ordinary shares and 965,155 series C shares, and after the ongoing transfer of ordinary shares to participants in LTI 2020 and LTI 2021 and the repurchase of series C shares as set out above, BONESUPPORT will hold no own ordinary shares and 965,155 own series C shares, intended for ongoing incentive programs.
The series C shares carry one-tenth of a vote per share and do not entitle to dividends.
© Modular Finance, source